Friess Associates’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Friess Associates’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-34,500	Closed	-$765K	–	184
2016 Q3	$765K	Hold	34,500	–	–	0.07%	95
2016 Q2	$630K	Hold	34,500	–	–	0.06%	92
2016 Q1	$628K	Hold	34,500	–	–	0.06%	95
2015 Q4	$582K	Buy	+34,500	New	+$586K	0.05%	101
2015 Q2	–	Sell	-41,073	Closed	-$899K	–	180
2015 Q1	$899K	Buy	+41,073	New	+$886K	0.07%	91

Other funds holding ENTL

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

DGI

Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

IBT

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Friess Associates's ENTL Position: Q4 2016 in Review

Friess Associates sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2016, closing a stake of 34,500 shares — an estimated $765K sold.

Friess Associates first reported a position in ENTL in Q1 2015 and held it in 5 quarters. The position peaked at $899K in Q1 2015. 63 funds tracked by Wall St. Rank hold ENTL as of Q4 2016.

Friess Associates reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Friess Associates sold 34,500 Entellus Medical, Inc. Common Stock shares in Q4 2016, an estimated $765K.
Friess Associates first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 5 quarters.
Friess Associates's Entellus Medical, Inc. Common Stock position peaked at $899K in Q1 2015.
63 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2016.

Based on Friess Associates's 13F filing for Q4 2016, filed 14 Feb 2017.